Diaphorina citri psyllid: psy4082


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80------
MRAAGYYQLLWHRVSVHFLARVGIMVNAPLRTLLFISMDGRKMGYGSMQGIPMVASSPVRHDSPIGMNALEVTSYQPPWKALSDFR
cccccEEEEEEEEEcccccEEEEEEcccccHHHHHHHHccccccccccccccEECccccccccccccccEEEECcccccccccccc
***AGYYQLLWHRVSVHFLARVGIMVNAPLRTLLFISMDGRKMGYGSM*GIPM********************SYQPPWKALSDFR
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MRAAGYYQLLWHRVSVHFLARVGIMVNAPLRTLLFISMDGRKMGYGSMQGIPMVASSPVRHDSPIGMNALEVTSYQPPWKALSDFR

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Insulin gene enhancer protein ISL-1 Binds to one of the cis-acting domain of the insulin gene enhancer.confidentP61374
Insulin gene enhancer protein isl-1 Binds to one of the cis-acting domain of the insulin gene enhancer. May be involved in subtype specialization of primary motoneurons.confidentP53405
Insulin gene enhancer protein ISL-1 Binds to one of the cis-acting domain of the insulin gene enhancer.confidentP61371

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0003705 [MF]RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activityprobableGO:0003700, GO:0003674, GO:0001071, GO:0000981
GO:0043433 [BP]negative regulation of sequence-specific DNA binding transcription factor activityprobableGO:0009889, GO:0051090, GO:0019219, GO:0080090, GO:0019222, GO:0060255, GO:0031326, GO:0031323, GO:0044092, GO:2000112, GO:0050794, GO:0050789, GO:0006355, GO:0010556, GO:0065007, GO:0051171, GO:2001141, GO:0008150, GO:0065009, GO:0051252, GO:0010468
GO:0005634 [CC]nucleusprobableGO:0043231, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043227, GO:0043226
GO:0000980 [MF]RNA polymerase II distal enhancer sequence-specific DNA bindingprobableGO:0005488, GO:0044212, GO:0043565, GO:0001067, GO:0003677, GO:0001012, GO:0001158, GO:0000976, GO:0000977, GO:0003676, GO:0000975, GO:0003674, GO:0097159, GO:1901363, GO:0035326
GO:0045944 [BP]positive regulation of transcription from RNA polymerase II promoterprobableGO:0009893, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:2001141, GO:0031323, GO:0010628, GO:0050789, GO:0080090, GO:0010604, GO:0051171, GO:0009891, GO:2000112, GO:0019219, GO:0010556, GO:0065007, GO:0048518, GO:0010468, GO:0045935, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0045893, GO:0051173, GO:0051252, GO:0051254, GO:0006355, GO:0010557, GO:0006357, GO:0048522
GO:0007521 [BP]muscle cell fate determinationprobableGO:0032502, GO:0045165, GO:0009987, GO:0048869, GO:0001709, GO:0044767, GO:0061061, GO:0044763, GO:0030154, GO:0008150, GO:0042693, GO:0042692, GO:0044699, GO:0048856
GO:0070983 [BP]dendrite guidanceprobableGO:0032502, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0016358, GO:0006928, GO:0031175, GO:0009653, GO:0007275, GO:0044699, GO:0000904, GO:0000902, GO:0048869, GO:0016043, GO:0032989, GO:0071840, GO:0048666, GO:0048667, GO:0032501, GO:0030182, GO:0009987, GO:0044767, GO:0044763, GO:0048731, GO:0022008, GO:0032990, GO:0048699, GO:0048858, GO:0007399, GO:0048856, GO:0048813, GO:0048812, GO:0008150
GO:0046665 [BP]amnioserosa maintenanceprobableGO:0032502, GO:0044767, GO:0001700, GO:0032501, GO:0048871, GO:0044707, GO:0060249, GO:0048856, GO:0042592, GO:0009790, GO:0009792, GO:0008150, GO:0065007, GO:0001894, GO:0065008, GO:0007275, GO:0044699
GO:0008284 [BP]positive regulation of cell proliferationprobableGO:0042127, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0032755 [BP]positive regulation of interleukin-6 productionprobableGO:0051240, GO:0050789, GO:0001817, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0032675, GO:0001819
GO:0007362 [BP]terminal region determinationprobableGO:0032502, GO:0007389, GO:0032501, GO:0009880, GO:0044707, GO:0009790, GO:0009948, GO:0048856, GO:0044767, GO:0008595, GO:0009952, GO:0008150, GO:0003002, GO:0000578, GO:0035282, GO:0009798, GO:0007351, GO:0007350, GO:0007275, GO:0044699, GO:0007354
GO:0033147 [BP]negative regulation of intracellular estrogen receptor signaling pathwayprobableGO:0033144, GO:0033146, GO:0009968, GO:0033143, GO:0009966, GO:0048585, GO:0048583, GO:0050794, GO:0008150, GO:0023057, GO:0065007, GO:0010648, GO:0023051, GO:0048519, GO:0010646, GO:0050789, GO:0048523
GO:0090074 [BP]negative regulation of protein homodimerization activityprobableGO:0032091, GO:0051098, GO:0051100, GO:0043496, GO:0008150, GO:0043393, GO:0044092, GO:0065007, GO:0065009
GO:0032760 [BP]positive regulation of tumor necrosis factor productionprobableGO:0001817, GO:0051240, GO:0032680, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0050789, GO:0001819
GO:0071657 [BP]positive regulation of granulocyte colony-stimulating factor productionprobableGO:1901258, GO:1901256, GO:0071655, GO:0050789, GO:0001817, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0051240, GO:0001819
GO:0001105 [MF]RNA polymerase II transcription coactivator activityprobableGO:0001190, GO:0003713, GO:0003712, GO:0001104, GO:0001076, GO:0003674, GO:0000989, GO:0000988
GO:0008293 [BP]torso signaling pathwayprobableGO:0080090, GO:0019222, GO:0031326, GO:0031323, GO:0023052, GO:0007165, GO:0007166, GO:0007167, GO:0007169, GO:0050789, GO:0044699, GO:0051716, GO:2000112, GO:0060255, GO:0006357, GO:0065007, GO:0010468, GO:0019219, GO:0009987, GO:0009889, GO:0050794, GO:0044763, GO:0051171, GO:2001141, GO:0007154, GO:0044700, GO:0050896, GO:0051252, GO:0006355, GO:0010556, GO:0008150
GO:0060913 [BP]cardiac cell fate determinationprobableGO:0032502, GO:0007507, GO:0060911, GO:0044707, GO:0072358, GO:0048869, GO:0032501, GO:0001709, GO:0035051, GO:0044767, GO:0048513, GO:0072359, GO:0045165, GO:0044763, GO:0048731, GO:0030154, GO:0008150, GO:0009987, GO:0007275, GO:0044699, GO:0048856
GO:0032729 [BP]positive regulation of interferon-gamma productionprobableGO:0051240, GO:0032649, GO:0001817, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0050789, GO:0001819
GO:0032725 [BP]positive regulation of granulocyte macrophage colony-stimulating factor productionprobableGO:0032645, GO:0051240, GO:0001817, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0050789, GO:0001819
GO:0003007 [BP]heart morphogenesisprobableGO:0032502, GO:0007507, GO:0009887, GO:0032501, GO:0044707, GO:0048513, GO:0048856, GO:0044767, GO:0072359, GO:0072358, GO:0008150, GO:0048731, GO:0009653, GO:0007275, GO:0044699
GO:0043388 [BP]positive regulation of DNA bindingprobableGO:0051099, GO:0051098, GO:0051101, GO:0065007, GO:0044093, GO:0008150, GO:0065009
GO:0010575 [BP]positive regulation vascular endothelial growth factor productionprobableGO:0051240, GO:0010574, GO:0001817, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0050789, GO:0001819
GO:0048542 [BP]lymph gland developmentprobableGO:0032502, GO:0002376, GO:0032501, GO:0044707, GO:0048856, GO:0007275, GO:0044767, GO:0048513, GO:0008150, GO:0048731, GO:0048732, GO:0048534, GO:0044699, GO:0002520
GO:0008045 [BP]motor neuron axon guidanceprobableGO:0032502, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0031175, GO:0007411, GO:0009653, GO:0007275, GO:0044699, GO:0000904, GO:0000902, GO:0042330, GO:0048869, GO:0016043, GO:0032989, GO:0071840, GO:0048666, GO:0048667, GO:0032501, GO:0006935, GO:0030182, GO:0009987, GO:0044767, GO:0008150, GO:0007409, GO:0048731, GO:0042221, GO:0022008, GO:0048858, GO:0040011, GO:0048699, GO:0032990, GO:0009605, GO:0050896, GO:0048856, GO:0007399, GO:0048812, GO:0044763
GO:0030331 [MF]estrogen receptor bindingprobableGO:0035258, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0021522 [BP]spinal cord motor neuron differentiationprobableGO:0032502, GO:0032501, GO:0048699, GO:0048856, GO:0007399, GO:0030182, GO:0021515, GO:0048869, GO:0021517, GO:0030154, GO:0021510, GO:0008150, GO:0009987, GO:0044763, GO:0044699, GO:0044707, GO:0048731, GO:0022008, GO:0007275, GO:0021953, GO:0007417
GO:0032731 [BP]positive regulation of interleukin-1 beta productionprobableGO:0032652, GO:0032651, GO:0051240, GO:0001817, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0032732, GO:0050789, GO:0001819
GO:0032730 [BP]positive regulation of interleukin-1 alpha productionprobableGO:0032652, GO:0032650, GO:0051240, GO:0001817, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0032732, GO:0050789, GO:0001819
GO:0035310 [BP]notum cell fate specificationprobableGO:0060573, GO:0030154, GO:0035220, GO:0007275, GO:0044699, GO:0007389, GO:0048869, GO:0001708, GO:0008150, GO:0048513, GO:0032502, GO:0032501, GO:0009987, GO:0044767, GO:0060581, GO:0003002, GO:0035309, GO:0045165, GO:0044707, GO:0007444, GO:0048856, GO:0044763, GO:0048731
GO:0008407 [BP]chaeta morphogenesisprobableGO:0032502, GO:0009887, GO:0032501, GO:0044707, GO:0007423, GO:0048856, GO:0044767, GO:0048513, GO:0008150, GO:0044699, GO:0048731, GO:0009653, GO:0007275, GO:0022416
GO:0032735 [BP]positive regulation of interleukin-12 productionprobableGO:0032655, GO:0051240, GO:0001817, GO:0065007, GO:0051239, GO:0048518, GO:0008150, GO:0050789, GO:0001819
GO:0045892 [BP]negative regulation of transcription, DNA-dependentprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:0031326, GO:0031324, GO:0031323, GO:0010629, GO:0050789, GO:0010605, GO:0019222, GO:2000112, GO:2000113, GO:0060255, GO:0065007, GO:0048519, GO:0010468, GO:0045934, GO:0019219, GO:0009889, GO:0050794, GO:0008150, GO:0051171, GO:0051172, GO:2001141, GO:0051253, GO:0051252, GO:0006355, GO:0010556, GO:0010558, GO:0048523
GO:0001102 [MF]RNA polymerase II activating transcription factor bindingprobableGO:0001085, GO:0033613, GO:0008134, GO:0003674, GO:0005488, GO:0005515
GO:0003682 [MF]chromatin bindingprobableGO:0003674, GO:0005488
GO:0042517 [BP]positive regulation of tyrosine phosphorylation of Stat3 proteinprobableGO:0019220, GO:0009893, GO:0019222, GO:0051246, GO:0031325, GO:0048584, GO:0048583, GO:0051247, GO:0023056, GO:0023051, GO:0010647, GO:0010646, GO:0010627, GO:0050789, GO:0080090, GO:0010604, GO:0009966, GO:0009967, GO:0010562, GO:0042516, GO:0042531, GO:0032270, GO:0031399, GO:0048518, GO:0065007, GO:0010740, GO:0042325, GO:0046427, GO:0045937, GO:0046425, GO:0060255, GO:0031323, GO:0050794, GO:0051174, GO:0008150, GO:0042509, GO:0042327, GO:0032268, GO:0050731, GO:0050730, GO:0031401, GO:0001932, GO:0001934, GO:0048522
GO:0007391 [BP]dorsal closureprobableGO:0048598, GO:0002009, GO:0001700, GO:0048856, GO:0044707, GO:0032501, GO:0060429, GO:0016331, GO:0009888, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0048729, GO:0009653, GO:0032502, GO:0007275, GO:0044699
GO:0007390 [BP]germ-band shorteningprobableGO:0048598, GO:0032502, GO:0001700, GO:0032501, GO:0044707, GO:0048856, GO:0044767, GO:0009790, GO:0009792, GO:0008150, GO:0009653, GO:0007275, GO:0044699

Prediction of Enzyme Commission Number ?

No EC number assigned to the protein, probably not an enzyme!


Spatial Structural Prediction

Structural Models Based on Templates

Template: 2RGT, chain A
Confidence level:confident
Coverage over the Query: 49-74
View the alignment between query and template
View the model in PyMOL